Related Experiment Videos
Polymorphonuclear leukocyte activation by a synthetic muramyl dipeptide analog
Infection and Immunity
|December 1, 1982
Summary
N alpha-(N-Acetylmuramyl-L-alanyl-D-isoglutaminyl)-N epsilon -stearoyl-L-lysine, a synthetic muramyl dipeptide derivative, enhances immune cell activity. This adjuvant boosts chemotaxis, phagocytosis, and superoxide anion production in mouse immune cells, indicating potential immunomodulatory effects.
Area of Science:
- Immunology
- Biochemistry
Background:
- Muramyl dipeptide is a known immune stimulant.
- Synthetic derivatives offer potential for enhanced immunomodulatory properties.
Purpose of the Study:
- To investigate the immunomodulatory effects of N alpha-(N-Acetylmuramyl-L-alanyl-D-isoglutaminyl)-N epsilon -stearoyl-L-lysine.
- To assess its impact on polymorphonuclear cell functions.
Main Methods:
- In vitro and in vivo studies using mouse peritoneal polymorphonuclear cells.
- Evaluation of chemotactic mobility, phagocytic activity, and superoxide anion production.
- Treatment of mice with the adjuvant prior to Escherichia coli inoculation.
Main Results:
- The synthetic muramyl dipeptide derivative significantly enhanced chemotactic mobility of immune cells, both in vitro and in vivo.
- Transient enhancement of phagocytic activity was observed with in vitro preincubation.
- Subcutaneous adjuvant treatment in mice led to significantly greater phagocytic activity and superoxide anion release compared to controls.
Conclusions:
- N alpha-(N-Acetylmuramyl-L-alanyl-D-isoglutaminyl)-N epsilon -stearoyl-L-lysine acts as a potent immune adjuvant.
- It effectively stimulates key functions of polymorphonuclear cells, suggesting therapeutic potential.